Featured Research

from universities, journals, and other organizations

Researchers Identify Protein That Overcomes Leptin Resistance

Date:
April 19, 2002
Source:
Beth Israel Deaconess Medical Center
Summary:
The identification of a protein that enables the body to overcome resistance to the hormone leptin could help scientists move one step closer to creating a drug therapy to help prevent and treat obesity. The findings, made by researchers at Beth Israel Deaconess Medical Center (BIDMC), are reported in the April 16 issue of Developmental Cell.

BOSTON – The identification of a protein that enables the body to overcome resistance to the hormone leptin could help scientists move one step closer to creating a drug therapy to help prevent and treat obesity. The findings, made by researchers at Beth Israel Deaconess Medical Center (BIDMC), are reported in the April 16 issue of Developmental Cell.

Nearly all obese individuals are resistant to leptin, the hormone that signals the brain that our appetites are satisfied and we can stop eating. For this reason, explains study co-senior author Barbara Kahn, M.D., Chief of Endocrinology and Metabolism at BIDMC, efforts made several years ago to use leptin in drug form to treat obesity were largely unsuccessful. “The majority of obese people actually have high levels of leptin,” explains Kahn, who is a Professor of Medicine at Harvard Medical School. “But they are unable to put it to use.”

In this new research, Kahn, together with co-senior author Benjamin Neel, M.D., Ph.D., – Director of the Cancer Biology Program at BIDMC who studies the biological functions of molecules known as protein-tyrosine phosphatases – initially began studying PTP1B (protein tyrosine phosphatase 1B) to determine its role in regulating insulin receptor signaling. “We hypothesized that in the absence of the PTP1B protein, you would have increased insulin sensitivity and protection against type 2 diabetes,” adds Kahn.

To test this hypothesis, researchers created a group of knockout mice, which lacked the PTP1B protein. As expected, these mice displayed hypersensitivity to insulin under ambient conditions as well as when they were given a glucose test. “This made it unambiguous that PTP1B was indeed increasing insulin sensitivity,” Neel explains. “What was unanticipated, however, was that the [knockout] mice were surprisingly lean.

In fact, when fed a high-fat diet, the PTP1B knockout mice gained much less weight and showed markedly diminished body fat when compared with a group of control mice. “They turned out to be resistant to a high-fat diet that is equivalent to what most Americans probably routinely consume,” adds Neel, who is also a Professor of Medicine at Harvard Medical School.

Further testing revealed that the knockout mice were exhibiting increased energy expenditure, “comparable to highly trained athletes,” according to Neel, who adds that the authors began to consider that PTP1B was regulating the leptin signaling pathway, probably by targeting the Jak2 protein molecule.

This finding, for the first time, offers scientists a molecular approach to overcome leptin resistance, and provides a target for the development of drugs to treat both obesity and diabetes. “Since almost all forms of obesity are leptin-resistant, a drug that would act downstream of the leptin receptor could conceivably result in significant weight loss,” says Neel. “Since PTP1B additionally acts to lower insulin resistance, it could, in principle, provide a very powerful approach to treating diabetes as well.”

Study co-authors include BIDMC researchers Janice M. Zabolotny, Ph.D., Kendra K. Bence-Hanulec, Ph.D., Fawaz Haj, Ph.D., Yongping Wang, M.S., Yasuhiko Minokoshi, M.D., Ph.D., Young-Bum Kim, Ph.D., and Joel K. Elmquist, D.V.M., Ph.D., and Milennium Pharmaceuticals researchers Alain Stricker-Krongrad, Ph.D. and Louis A. Tartaglia, Ph.D.

The study was funded by grants from the National Institutes of Health (NIH) and the American Diabetes Association.

Beth Israel Deaconess Medical Center is a major patient care, research and teaching affiliate of Harvard Medical School and a founding member of CareGroup Healthcare System. Beth Israel Deaconess is the third largest recipient of National Institutes of Health research funding among independent U.S. hospitals.


Story Source:

The above story is based on materials provided by Beth Israel Deaconess Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Beth Israel Deaconess Medical Center. "Researchers Identify Protein That Overcomes Leptin Resistance." ScienceDaily. ScienceDaily, 19 April 2002. <www.sciencedaily.com/releases/2002/04/020419065142.htm>.
Beth Israel Deaconess Medical Center. (2002, April 19). Researchers Identify Protein That Overcomes Leptin Resistance. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2002/04/020419065142.htm
Beth Israel Deaconess Medical Center. "Researchers Identify Protein That Overcomes Leptin Resistance." ScienceDaily. www.sciencedaily.com/releases/2002/04/020419065142.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins